Apyx Medical (APYX) EBIT (2016 - 2025)
Historic EBIT for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$832000.0.
- Apyx Medical's EBIT rose 7711.14% to -$832000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year increase of 5594.03%. This contributed to the annual value of -$18.8 million for FY2024, which is 918.94% down from last year.
- As of Q3 2025, Apyx Medical's EBIT stood at -$832000.0, which was up 7711.14% from -$2.6 million recorded in Q2 2025.
- In the past 5 years, Apyx Medical's EBIT registered a high of -$832000.0 during Q3 2025, and its lowest value of -$6.6 million during Q1 2024.
- Over the past 5 years, Apyx Medical's median EBIT value was -$4.6 million (recorded in 2023), while the average stood at -$4.2 million.
- Its EBIT has fluctuated over the past 5 years, first soared by 7933.4% in 2023, then plummeted by 34914.98% in 2024.
- Quarter analysis of 5 years shows Apyx Medical's EBIT stood at -$1.7 million in 2021, then tumbled by 250.65% to -$5.9 million in 2022, then increased by 2.65% to -$5.8 million in 2023, then surged by 47.23% to -$3.0 million in 2024, then soared by 72.7% to -$832000.0 in 2025.
- Its last three reported values are -$832000.0 in Q3 2025, -$2.6 million for Q2 2025, and -$3.1 million during Q1 2025.